Acetylsalicylic acid Recruiting Phase 4 Trials for Saphenous Vein Graft Disease Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02053909Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis